Angi Inc SEC Filings

BlackRock, Inc. has filed Amendment No. 1 to Schedule 13G disclosing its passive ownership in Angi Inc. (ANGI) as of 30 June 2025.

• Total beneficial ownership: 6,348,209 Class A shares.
• Percent of outstanding class: 13.2%.
• Sole voting power: 6,245,585 shares; shared voting power: 0.
• Sole dispositive power: 6,348,209 shares; shared dispositive power: 0.
• The position is held across multiple BlackRock business units; iShares Core S&P Small-Cap ETF individually holds >5% of the class.
• BlackRock certifies the shares were acquired and are held in the ordinary course of business, without intent to influence control.

The filing classifies BlackRock as a parent holding company/control person (Item 3(g)) and is signed by Managing Director Spencer Fleming on 29 July 2025.

The Vanguard Group filed Amendment No. 7 to its Schedule 13G disclosing its beneficial ownership of Angi Inc. (NASDAQ: ANGI) common stock as of 30 June 2025.

The filing shows Vanguard beneficially owns 4,899,419 shares, representing 10.21 % of Angi’s outstanding common shares. Vanguard reports 0 shares with sole voting power and 27,425 shares with shared voting power. Dispositive authority is larger, with 4,823,182 shares under sole dispositive power and 76,237 shares under shared dispositive power.

Vanguard is classified as an investment adviser (Type IA) and certifies that the stake is held in the ordinary course of business, not to influence control. Because the holding exceeds the 10 % threshold, Vanguard must report under Section 13(d) of the Exchange Act, but the passive Schedule 13G filing signals no activist intent.

The disclosure confirms a large, diversified institution continues to maintain a significant passive position in Angi, potentially supporting market liquidity and investor confidence while exerting limited direct governance influence due to the absence of sole voting power.

Angi director Suzy Welch reported the vesting of restricted stock units (RSUs) on June 20, 2025. The transaction involved the conversion of 2,580 RSUs into Class A Common Stock on a one-for-one basis, increasing her direct holdings to 19,003 shares.

Key details of the RSU grant:

• Original grant date: June 20, 2023
• Vesting schedule: Equal installments over three years
• Vesting condition: Continued service as director
• Conversion rate: One-for-one into Class A Common Stock

The Form 4 was filed by Shannon M. Shaw as Attorney-in-Fact for Welch on June 23, 2025. This transaction represents a routine vesting event of director compensation and does not involve any open market transactions.

Angi director Jeremy Philips reported the vesting of restricted stock units (RSUs) on June 20, 2025. The transaction involved the conversion of 2,580 RSUs into Class A Common Stock on a one-for-one basis.

Key transaction details:

• Acquired 2,580 shares of Class A Common Stock through RSU conversion
• Post-transaction direct ownership increased to 12,207 shares
• RSUs were granted on June 20, 2023, with a three-year vesting schedule in equal annual installments
• Transaction was executed under transaction code 'M' (exercise or conversion of derivative security)

The Form 4 was filed by Shannon M. Shaw as Attorney-in-Fact for Jeremy Philips on June 23, 2025, within the required reporting timeline. This transaction represents a scheduled vesting event rather than an open market transaction.

Form 4 snapshot: On 06/17/2025 Angi Inc. (ANGI) director Sandra M. Buchanan reported an award of 16,436 restricted stock units (RSUs). The transaction code “A” confirms it was a grant, not a market purchase or sale, and was executed at $0 cost under the company’s equity compensation plan. Each RSU converts into one share of Class A common stock.

The RSUs vest in three equal annual installments on each anniversary of the 06/17/2025 grant date, contingent on continued board service. Under Buchanan’s deferral election, any vested shares will be delivered in a lump-sum after her service ends. After this grant, she beneficially owns 16,436 derivative securities, held directly. No dispositions or additional transactions were disclosed.

No ordinary shares were bought or sold, and the filing does not reference a Rule 10b5-1 trading plan. The event is a routine director compensation grant with minimal direct market impact.

Form 4 snapshot – Angi Inc. (ANGI), filed 06/20/2025: Director Alesia J. Haas reported the grant of 16,436 Restricted Stock Units (RSUs) on 06/17/2025. Each RSU converts into one share of Class A common stock upon settlement.

Key transaction details:

• Transaction code: A (award/grant, no open-market purchase or sale).
• Price: $0 – equity granted as compensation.
• Vesting schedule: Equal annual installments over three years on the anniversary of the 06/17/2025 grant date, contingent on continued service.
• Deferral election: Any vested RSUs will be settled in a lump sum after termination of service.
• Post-transaction beneficial ownership: 16,436 Class A shares held directly through RSUs.

No sales, option exercises, or other derivative activities were reported. The filing therefore reflects routine director compensation rather than a market-driven trade. While the grant modestly increases insider equity alignment, it does not signal a change in corporate outlook or provide new information on Angi’s operational or financial performance.